Table 3

Incidence rate of MSI and LOH, number of alleles isolated, and allelic imbalance noticed for each marker
Marker Chr./Locus No of positive patients Incidence of MSI / LOH No. of alleles isolated Allelic imbalance
TP53-Alu 17p13.1 34 39.08% 11 L 0.00 - 0.64
U 1.52 - 2.61
Mfd41 17p12-11.1 27 31.03% 8 L 0.00 - 0.56
U 1.37 - 2.82
Mfd28 10pter 22 25.28% 5 L 0.00 -0 .61
U 1.42 - 5.83
Bat-26 2p 4 4.59% 3 L 0.30 - 0.52
U 1.42 - 1.54
Bat-40 1p13.1 0 0% 4 L 0.73 - 0.79
U 0.94 - 1.22

L= lower allelic imbalance range.

U= upper allelic imbalance range.

Kamat et al.

Kamat et al. BMC Cancer 2012 12:373   doi:10.1186/1471-2407-12-373

Open Data